Ac immune holds annual general meeting of shareholders

Ac immune holds annual general meeting of shareholders shareholders approved all resolutions as proposed by the board of directors lausanne, switzerland, june 23, 2023 – ac immune sa (nasdaq: aciu), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that the company held its annual general meeting per swiss law. shareholders cast their votes in person at the annual general meeting or through the independent proxy appointed by the shareholders.
ACIU Ratings Summary
ACIU Quant Ranking